ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Apoptosis"

  • 2018 American Transplant Congress

    Exenatide Reduces Ischemia/Reperfusion Injury in Donation after Cardiac Death Rat Kidney Transplantation

    H. Yang,1 Y. Shi,2 X. Li,1 C. Long,1 Z. Xu,1 L. Luo,1 W. Luo,1 Y. Zhang,1 T. Zeng,3 M. Chen,4 H. Li,5 Z. Wang.5

    1Department of Organ Transplantation, People's Hospital of Jiangxi Province, Nanchang, Jiangxi Province, China; 2Department of Pathology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China; 3Department of Urologic Surgery, People's Hospital of Jiangxi Province, Nanchang, Jiangxi Province, China; 4Department of Vascular Surgery, People's Hospital of Jiangxi Province, Nanchang, Jiangxi Province, China; 5Department of Urologic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.

    Background: Exenatide provide protection against warm Ischemia/Reperfusion Injury (IRI) in the rat heart and kidney. We hypothesized that Exenatide reduces IRI in a rat donation…
  • 2018 American Transplant Congress

    Recombinant Relaxin Protects Liver Transplants from Ischemia-Reperfusion Damage via Hepatocyte Glucocorticoid Receptor: From Bench-to-Bedside

    S. Kageyama,1 K. Nakamura,1 T. Ito,1 A. Aziz,1 B. Ke,1 R. Sossa,2 E. Reed,2 F. Kaldas,1 R. Busuttil,1 J. Kupiec-Weglinski.1

    1Surgery, Division of Liver Transplantation, UCLA, Los Angeles, CA; 2Pathology, UCLA, Los Angeles, CA.

    Hepatic ischemia-reperfusion injury (IRI) represents a major risk factor of early graft dysfunction and acute/chronic rejection as well as a key obstacle to expanding the…
  • 2018 American Transplant Congress

    GDF15 Preventing Renal Ischemia Reperfusion Injury

    C. Zhu,1,2 A. Patel,1 Y. Su,1,2 J. Jiang,1 D. Lian,1 A. Sener,1 W. Min,1 P. Luke,1 D. Quan,1 K. Liu,2 X. Zheng.1

    1University of Western Ontario, London, ON, Canada; 2Jilin University, ChangChun, China.

    Rationale: Ischemia reperfusion (I/R) injury still remains one of main causes of early renal dysfunction in kidney transplantation. There are no effective treatments for preventing…
  • 2018 American Transplant Congress

    QPI-1002, a siRNA Targeting p53: Improvement in Outcomes Following Acute Kidney Injury (AKI): Cardiac Surgery to AKI Donors

    J. Tchervenkov,2 E. Squiers,1 R. Stratta,3 D. Odenheimer,2 D. Rothenstein,2 QPI-1002 DGF Study Group.

    1Quark Pharmaceuticals, Fremont; 2McGill University Health, Montreal, Canada; 3Wake Forest School of Medicine Centre, Winston-Salem.

    Background: QPI-1002 has been observed to statistically reduce the incidence, severity and duration of AKI in a large Phase 2 study of AKI following cardiac…
  • 2018 American Transplant Congress

    Apoptotic Exosome-Like Vesicles Induce Endothelial Cell Plasticity

    F. Migneault,1,2,4 M. Dieudé,1,2,4 J. Turgeon,1,4 D. Beillevaire,1,2,4 M-.P. Hardy,2,3,4 C. Perreault,2,3,4 M-.J. Hébert.1,2,4

    1CRCHUM, Montreal, QC, Canada; 2Université de Montréal, Montreal, QC, Canada; 3IRIC, Montreal, QC, Canada; 4CNTRP, Montreal, QC, Canada.

    Acute vascular rejection of renal allografts is associated with increased endothelial apoptosis which contributes to the development of transplant vasculopathy. We previously showed that apoptotic…
  • 2018 American Transplant Congress

    Recombinant Thrombomodulin alpha Attenuates Kidney Graft Damage after Long Cold Ischemia Time in a Rat Kidney Transplant Model

    S. Tamaki,1 K. Shinoda,1 M. Shimoda,2 S. Morita,1 H. Asanuma,1 M. Oya.1

    1Urology, Keio University School of Medicine, Tokyo, Japan; 2Pathology, Keio University School of Medicine, Tokyo, Japan.

    Objectives: Thrombomodulin (TM) extensively expresses on the endothelial cells in the steady state and is known to prevent hypercoagulation via combining with thrombin and inactivating…
  • 2018 American Transplant Congress

    Linking Donor Ischemia Reperfusion Injury (IRI) to Costimulatory Blockade Resistant Murine Heart Graft Rejection through Complement-Initiated Necroptosis

    R. Ang, N. Chun, A. Ting, P. Heeger.

    Immunology Institute, Translational Transplant Research, Icahn School of Medicine at Mount Sinai, New York, NY.

    We previously showed that prolonged cold ischemic storage (CIS) of donor B6 hearts results in complement dependent, CTLA4Ig-resistant rejection in BALB/c recipients. In this system,…
  • 2018 American Transplant Congress

    MERTK Mediates Transplant Tolerance via IFN-a Regulation of MDSCs and Tregs

    L. Zhang, M. DeBerge, E. Thorp, X. Luo.

    Northwestern University Feinberg School of Medicine, Chicago.

    Introduction: MERTK is one of the TAM receptor tyrosine kinases (RTKs) that mediate homeostatic phagocytosis of apoptotic cells, and transmit regulatory signals that modulate immune…
  • 2018 American Transplant Congress

    Enhancement of Intrinsic Apoptosis via Bcl-2 Inhibition Promotes Induction of Robust Mixed Chimerism and Renal Allograft Tolerance without Myelosuppression in Nonhuman Primates

    T. Oura,1 A. Dehnadi,1 I. Rosales,1 H. Sasaki,1 P. Cippa,2 R. Fehr,2 A. Cosimi,1 T. Kawai.1

    1Surgery, Center for Transplantation Science, Massachusetts General Hospital, Boston, MA; 2Medicine, University of Zurich, Zurich, Switzerland.

    Background: Successful induction of mixed chimerism (MC) and renal allograft tolerance has been achieved in both nonhuman primate (NHP) and man following conditioning that included…
  • 2018 American Transplant Congress

    Involvement of Aldehyde Dehydrogenase 2 (ALDH2) in Fatty Liver Graft Protection Mechanisms against Cold Ischemic Injury

    A. Panisello-Rosello,1 A. Lopez,2 C. Castro,2 S. Bellogi,1 E. Folch-Puy,1 A. Rolo,3 C. Palmeira,3 R. Adam, J. Roselló-Catafau.

    1Experimental Pathology, Instituto de Investigaciones Biomédicas de Barcelona, Barcelona, Catalonia, Spain; 2INSERM U935, Hôpital Paul Brousse, Paris, France; 3Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.

    Aldehyde dehydogenase (ALDH2) is a mitochondrial enzyme that recently has been involved in the cardioprotection against ischemia injury. No data are reported on the potential…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 13
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences